OMDA · XBRL financial data
Omada Health financial statements, every fiscal year
The same tables from 1 filing, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (OMDA's year ends in late December)
| In thousands of dollars | Dec 31, 2025 |
|---|---|
| Revenue from contracts with customers | 260,210 |
| Cost of revenue | 89,271 |
| Gross profit | 170,939 |
| Research and development | 40,683 |
| General and administrative | 52,184 |
| Total operating expenses | 182,911 |
| Operating income (loss) | (11,972) |
| Interest income | 5,305 |
| Interest expense | 2,534 |
| Income tax expense (benefit) | 0 |
| Net income (loss) | (12,778) |
| Earnings per share, basic USD per share | (0.35) |
| Earnings per share, diluted USD per share | (0.35) |
| Weighted average shares, basic thousands of shares | 36,639 |
| Weighted average shares, diluted thousands of shares | 36,639 |
Balance sheet
CSVFiscal years (OMDA's year ends in late December)
| In thousands of dollars | Dec 31, 2025 |
|---|---|
| Cash and cash equivalents | 222,036 |
| Accounts receivable | 34,585 |
| Inventory | 4,486 |
| Prepaid and other current assets | 8,288 |
| Total current assets | 272,934 |
| Property and equipment, net | 7,942 |
| Right-of-use asset | 0 |
| Goodwill | 13,240 |
| Total assets | 305,406 |
| Accounts payable | 10,276 |
| Accrued liabilities | 40,392 |
| Total current liabilities | 75,726 |
| Total liabilities | 75,726 |
| Accumulated deficit | (456,744) |
| Total stockholders' equity | 229,680 |
| Total liabilities and equity | 305,406 |
| Common shares outstanding (cover page) thousands of shares | 58,925 |
Cash flows
CSVFiscal years (OMDA's year ends in late December)
| In thousands of dollars | Dec 31, 2025 |
|---|---|
| Net income (loss) | (12,778) |
| Stock-based compensation | 12,955 |
| Depreciation and amortization | 5,491 |
| Net cash from operating activities | 18,252 |
| Purchases of property and equipment | 1,322 |
| Net cash from investing activities | (5,832) |
| Net cash from financing activities | 133,224 |
| Net change in cash | 145,644 |
Compare with peers
SIC 8000 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 8000 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Omada Health | 221,712 | 87,835 | 4,007* | 61.2M | — | 10-QJun 30, 2026 |
| Pennant Group | 18,389 | 302,251 | not reported | 35.1M | — | 10-QSep 30, 2026 |
| LifeStance Health Group | 225,943 | 435,354 | 99,912* | 382.1M | — | 10-QJun 30, 2026 |
| U S Physical Therapy | 24,887 | 214,059 | 34,370* | 14.9M | — | 10-QJun 30, 2026 |
| GeneDx Holdings | 60,317 | 114,440 | (28,981)* | 29.8M | 4.6 quarters | 10-QJun 30, 2026 |
| Privia Health Group | 412,200 | not reported | 1,100* | 127.7M | — | 10-QJun 30, 2026 |
| Talkspace | 39,159 | 61,672 | 11,385* | 165.8M | — | 10-QJun 30, 2026 |
| Strata Critical Medical | 35,136 | 74,081 | 9,458* | 89.3M | — | 10-QSep 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.